Dror led the firm’s investments in: Eikon Therapeutics, which employs revolutionary single molecule imaging technology to discover novel treatments for life-threatening diseases; Fabric, which is leveraging robotics to re-architect the supply chain; Vicarious Surgical, which applies robotics and virtual reality to minimally invasive surgeries; Atom Computing, which is building scalable quantum computers out of individual atoms; and Gatik, which is developing self-driving solutions for urban logistics — to name a few. Dror earned an MBA from Stanford Graduate School of Business and a BS in Computer Science, and graduated undergrad cum laude from Ben-Gurion University of the Negev for computer science and bioinformatics. Prior to earning his MBA, Dror held various R&D roles at NICE Systems (Nasdaq: NICE) and was part of an elite Special Forces unit of the Israeli Defense Forces.